Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Personalized Care Plans : Every patient receives a customized treatment plan tailored to their unique goals
GLP-1 Impact One of the most notable drivers of peptide interest has been the surge in GLP-1 drug prescriptions
0.5 and 1mg sermorelin acetate for subcutaneous injection, which was FDA approved in 1997 for therapy in children with idiopathic short stature
Begin Treatment If appropriate, you receive a personalized medical weight loss plan with ongoing support
Cumulative incidence estimates are based on time from randomization to first EAC-confirmed cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke with non-CV death modeled as competing risk using the Aalen-Johansen estimator
Preparing Your Body and Mind The moments leading up to your injection are a great time to check in with your health goals
